Cmet-44. Her2 and Triple Negative Breast Cancer Patients Demonstrate an Earlier Time to Development of Brain Metastases

Abstract

This retrospective analysis showed that development/progression of CNS metastasis in patients on treatment with a PD-1 inhibitor has good concordance with systemic disease status. The incidence of CNS disease in patients on this therapy is comparable to historic cohorts treated with conventional chemotherapy. CMET-41. OVERALL SURVIVAL OF MELANOMA BRAIN